BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20702688)

  • 1. SV2 regulates neurotransmitter release via multiple mechanisms.
    Nowack A; Yao J; Custer KL; Bajjalieh SM
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C960-7. PubMed ID: 20702688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotrafficking of SV2 and synaptotagmin at the synapse.
    Yao J; Nowack A; Kensel-Hammes P; Gardner RG; Bajjalieh SM
    J Neurosci; 2010 Apr; 30(16):5569-78. PubMed ID: 20410110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam reverses synaptic deficits produced by overexpression of SV2A.
    Nowack A; Malarkey EB; Yao J; Bleckert A; Hill J; Bajjalieh SM
    PLoS One; 2011; 6(12):e29560. PubMed ID: 22220214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SV2A and SV2C contain a unique synaptotagmin-binding site.
    Schivell AE; Mochida S; Kensel-Hammes P; Custer KL; Bajjalieh SM
    Mol Cell Neurosci; 2005 May; 29(1):56-64. PubMed ID: 15866046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.
    Chang WP; Südhof TC
    J Neurosci; 2009 Jan; 29(4):883-97. PubMed ID: 19176798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
    Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic vesicle protein 2 enhances release probability at quiescent synapses.
    Custer KL; Austin NS; Sullivan JM; Bajjalieh SM
    J Neurosci; 2006 Jan; 26(4):1303-13. PubMed ID: 16436618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).
    Crowder KM; Gunther JM; Jones TA; Hale BD; Zhang HZ; Peterson MR; Scheller RH; Chavkin C; Bajjalieh SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15268-73. PubMed ID: 10611374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin.
    Schivell AE; Batchelor RH; Bajjalieh SM
    J Biol Chem; 1996 Nov; 271(44):27770-5. PubMed ID: 8910372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.
    Janz R; Goda Y; Geppert M; Missler M; Südhof TC
    Neuron; 1999 Dec; 24(4):1003-16. PubMed ID: 10624962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses.
    Vogl C; Tanifuji S; Danis B; Daniels V; Foerch P; Wolff C; Whalley BJ; Mochida S; Stephens GJ
    Eur J Neurosci; 2015 Feb; 41(4):398-409. PubMed ID: 25484265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptotagmin I synchronizes transmitter release in mouse hippocampal neurons.
    Nishiki T; Augustine GJ
    J Neurosci; 2004 Jul; 24(27):6127-32. PubMed ID: 15240804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the SV2-like protein SVOP produces no apparent deficits in laboratory mice.
    Yao J; de la Iglesia HO; Bajjalieh SM
    PLoS One; 2013; 8(7):e68215. PubMed ID: 23894296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV2 modulates the size of the readily releasable pool of secretory vesicles.
    Xu T; Bajjalieh SM
    Nat Cell Biol; 2001 Aug; 3(8):691-8. PubMed ID: 11483953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV2 mediates entry of tetanus neurotoxin into central neurons.
    Yeh FL; Dong M; Yao J; Tepp WH; Lin G; Johnson EA; Chapman ER
    PLoS Pathog; 2010 Nov; 6(11):e1001207. PubMed ID: 21124874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SV2B regulates synaptotagmin 1 by direct interaction.
    Lazzell DR; Belizaire R; Thakur P; Sherry DM; Janz R
    J Biol Chem; 2004 Dec; 279(50):52124-31. PubMed ID: 15466855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SV2 is the protein receptor for botulinum neurotoxin A.
    Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
    Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation is dispensable for sorting of synaptotagmin 1 but is critical for targeting of SV2 and synaptophysin to recycling synaptic vesicles.
    Kwon SE; Chapman ER
    J Biol Chem; 2012 Oct; 287(42):35658-35668. PubMed ID: 22908222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SV2 frustrating exocytosis at the semi-diffusor synapse.
    Vautrin J
    Synapse; 2009 Apr; 63(4):319-38. PubMed ID: 19140166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of synaptic vesicle protein 2 (SV2) isoforms.
    Bajjalieh SM; Frantz GD; Weimann JM; McConnell SK; Scheller RH
    J Neurosci; 1994 Sep; 14(9):5223-35. PubMed ID: 8083732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.